Israeli biotech BiomX is developing a pipeline of treatments for unmet medical needs, including cancer, inflammatory bowel disease and acne.  BiomX focuses on modulating the human microbiome – bacteria that reside in and on the human body – to boost immune-oncology treatments.

http://www.timesofisrael.com/biomx-raises-24-million-to-boost-bacteria-based-drugs/